Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
ACR-ABS-ACNM-ARS-SIR-SNMMI Practice Parameter for Radioembolization of Liver Malignancies.
Journal: American journal of clinical oncology
Published: September 03, 2025
18F-MK-6240 tau PET in patients at-risk for chronic traumatic encephalopathy.
Journal: Molecular neurodegeneration
Published: August 26, 2024
Identification of an APOE ε4-specific blood-based molecular pathway for Alzheimer's disease risk.
Journal: Alzheimer's & dementia (Amsterdam, Netherlands)
Published: September 11, 2023
Hematocrit and lactate trends help predict outcomes in trauma independent of CT and other clinical parameters.
Journal: Frontiers in radiology
Published: March 14, 2023
Annualized changes in rate of amyloid deposition and neurodegeneration are greater in participants who become amyloid positive than those who remain amyloid negative.
Journal: Neurobiology of aging
Published: July 06, 2022
Prediction of the local treatment outcome in patients with oropharyngeal squamous cell carcinoma using deep learning analysis of pretreatment FDG-PET images.
Journal: BMC cancer
Published: January 12, 2021
Prediction of the treatment outcome using machine learning with FDG-PET image-based multiparametric approach in patients with oral cavity squamous cell carcinoma.
Journal: Clinical radiology
Published: October 25, 2020
Prediction of the human papillomavirus status in patients with oropharyngeal squamous cell carcinoma by FDG-PET imaging dataset using deep learning analysis: A hypothesis-generating study.
Journal: European journal of radiology
Published: October 11, 2019
FDG-PET/CT activity leads to the diagnosis of unsuspected TB: a retrospective study.
Journal: BMC research notes
Published: April 17, 2018
ACR-ACNM Practice Parameter for the Performance of Dopamine Transporter (DaT) Single Photon Emission Computed Tomography (SPECT) Imaging for Movement Disorders.
Journal: Clinical nuclear medicine
Published: September 19, 2017
An amylin analog used as a challenge test for Alzheimer's disease.
Journal: Alzheimer's & dementia (New York, N. Y.)
Published: May 16, 2017
Last Updated: 09/26/2026